Athena Countouriotis, SVP and Chief Medical Officer at Halozyme, holds 13.64K shares in Halozyme (Ticker: HALO), holds ― shares in Cardiff Oncology (Ticker: CRDF), holds 26.87K shares in Turning Point Therapeutics (Ticker: TPTX).
What was Athena Countouriotis’s latest transaction?
Athena Countouriotis latest transaction was an Uninformative Buy of $84.59K.
What was Athena Countouriotis's most profitable transaction?
Athena Countouriotis’s most profitable transaction was an Informative Buy of TPTX stock on April 24, 2019. The return on the trade was 83.20%.
What is Athena Countouriotis's role in Halozyme?
Athena Countouriotis's role in Halozyme is SVP and Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.